Vanda Pharmaceuticals Inc. (VNDA) stock
VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.75−0.06 (-1.57%)
Close on Nov 18, 2026Market cap $226.76MP/E –Yield –
Vanda Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Vanda Pharmaceuticals's EV/EBITDA was 10.5× on Oct 31, 2023, against 10.3× a year earlier. Over the last 5 years it ranged from 1.5× to 113.2×, with a median of 15.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Oct 31, 2023 | 10.5× | −33.7 |
| 2022 | Dec 30, 2022 | 44.2× | +33.6 |
| 2021 | Dec 31, 2021 | 10.6× | −7.0 |
| 2020 | Dec 31, 2020 | 17.6× | −5.4 |
| 2019 | Dec 31, 2019 | 23.0× | −85.1 |
| 2018 | Dec 31, 2018 | 108.1× | +103.2 |
| 2016 | Jan 29, 2016 | 4.9× | −0.7 |
| 2015 | Dec 31, 2015 | 5.7× | +4.4 |
| 2011 | Jul 29, 2011 | 1.2× | – |
See a number that looks wrong?